---
title: "Age and underlying conditions linked to hospitalization and death after COVID-19 diagnosis, PCORne"
id: "medrxiv-17-how-age-and-underlying-conditions-affect-incidence-of-hospitalization-and-death"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-17-how-age-and-underlying-conditions-affect-incidence-of-hospitalization-and-death"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.18.26363440v1?rss=1"
published_at: "2026-09-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Age and underlying conditions linked to hospitalization and death after COVID-19 diagnosis, PCORne
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-17-how-age-and-underlying-conditions-affect-incidence-of-hospitalization-and-death
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.18.26363440v1?rss=1)
- **Published At:** 2026-09-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective cohort used PCORnet electronic health record data to assess associations between **age**, **underlying medical conditions**, and the incidence of **hospitalization** and **mortality** after documented **COVID-19** diagnosis during April 2022–March 2025. - The study included 1,662,679 adults aged ≥20 years with COVID-19. Outcomes evaluated were hospitalization within 16 days and death within 30 days of diagnosis. - Adjusted cumulative incidence (aCI) and aCI ratios (aCIR) were estimated using Poisson regression with cluster-robust sandwich standard errors, controlling for sociodemographic and health characteristics. - Age-stratified groups were 20–49, 50–64, 65–79, and 80+ years. Cumulative incidence of hospitalization rose from 4.7% to 22.6% across these age groups; mortality rose from 0.11% to 3.6%. - Within each age group, aCI for both outcomes increased with the number of underlying conditions, with the highest aCI among people with three or more conditions. - Specific UC categories analyzed included cancer, cardiac, hepatic, immunosuppression, metabolic, neurologic, pulmonary, renal, psychiatric, and other conditions; UCs—especially two or more—were associated with higher incidence of both outcomes across age groups. - The authors conclude that older age remained strongly associated with hospitalization and death after COVID-19 diagnosis since 2022, and adults with ≥2 underlying conditions generally had higher incidence of both outcomes across age groups. - The study was reviewed by CDC authorities and deemed not research under applicable federal regulations; data are not publicly available per PCORnet privacy policy. - One author disclosed consultancy and shareholding ties; other authors declared no conflicts. Specific numerical effect estimates and full model covariates were not detailed in the summary provided.
## Clinical Analysis & Structured Key Points
How age and underlying conditions affect incidence of hospitalization and death after documented COVID-19 diagnosis among individuals aged ≥20 years, a retrospective cohort study using PCORnet, April 2022 to March 2025 | medRxiv Skip to main content How age and underlying conditions affect incidence of hospitalization and death after documented COVID-19 diagnosis among individuals aged ≥20 years, a retrospective cohort study using PCORnet, April 2022 to March 2025 Emilia H Koumans , Gordana Derado , Melisa M Shah , Nathan Graff , Christine Draper , Sharon Saydah , Melissa Briggs-Hagen , Joshua Denson , Michael David Kappelman , Deepika Thacker , Edward J Schenck , Kshema Nagavedu , Tegan K Boehmer , Diane Emerton , Thomas Carton , Pragna Patel , Jason P Block , PCORnet Network Partners doi: https://doi.org/10.64898/2026.09.18.26363440 Emilia H Koumans 1 Centers for Disease Control and Prevention; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: exk0{at}cdc.gov Gordana Derado 1 Centers for Disease Control and Prevention; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Melisa M Shah 2 CDC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nathan Graff 1 Centers for Disease Control and Prevention; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christine Draper 3 Harvard Pilgrim Health Care Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sharon Saydah 1 Centers for Disease Control and Prevention; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Melissa Briggs-Hagen 1 Centers for Disease Control and Prevention; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Joshua Denson 4 Tulane University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Michael David Kappelman 5 University of North Carolina Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Deepika Thacker 6 Nemours Children's Clinic; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Edward J Schenck 7 Weill Cornell Medical College: Weill Cornell Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kshema Nagavedu 3 Harvard Pilgrim Health Care Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tegan K Boehmer 1 Centers for Disease Control and Prevention; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Diane Emerton 8 Harvard Health Care Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas Carton 9 Louisiana Public Health Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Pragna Patel 1 Centers for Disease Control and Prevention; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jason P Block 10 Harvard Medical School and Harvard Pilgrim Health Care Institute Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Abstract Background: COVID-19 vaccinations, therapeutics, and immunity from infection have reduced COVID-19 severity. It is unknown to what extent previously identified risk factors, age and underlying medical conditions (UC), remain associated with severe COVID-19 incidence. Methods: Using electronic health record (EHR) data from PCORnet, we identified individuals aged ≥20 years with COVID-19 during April 2022-March 2025. We used Poisson regression with cluster-robust sandwich standard errors to estimate adjusted cumulative incidence (aCI) and aCI ratios (aCIR) for hospitalization within 16 days and mortality within 30 days of COVID-19 diagnosis to estimate the association of UCs and UC categories, comparing those with an UC to those without (adjusted for sociodemographic and health characteristics). We examined aCI and aCIR for cancer, cardiac, hepatic, immunosuppression, metabolic, neurologic, pulmonary, renal, psychiatric, and other conditions by age groups: 20-49, 50-64, 65-79, and 80+ years. Results: Among 1,662,679 patients with COVID-19, the cumulative incidence of hospitalization (4.7%, 6.3%, 10.8%, 22.6%) and mortality (0.11%, 0.42%, 1.0%, 3.6%) increased across the 20-49, 50-64, 65-79, and 80+ year old age groups, respectively. Within each age group, aCI for hospitalization and mortality increased with number of UCs, with the highest aCI among those with 3 or more UCs. aCIR by age group demonstrated that UCs, especially 2 or more, were associated with incidence of both outcomes in all age groups. Conclusion: Since 2022, older age has remained strongly associated with hospitalization and mortality after COVID-19 diagnosis. Adults with two or more UCs generally had higher incidence of both outcomes across age groups. Competing Interest Statement Michael Kappelman is a consultant for Eli Lilly, Takeda, and Roche Genentech and a shareholder in Johnson & Johnson. The remaining authors have no conflicts to declare. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was reviewed by applicable authorities at the Centers for Disease Control and Prevention, deemed not research, and conducted consistent with applicable federal law and CDC policy (45 CFR part 46.102(l)(2), 21 CFR part 56; 42 USC section 241(d); 5 USC section 552a; 44 USC section 3501 et seq) I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Data not publicly available as part of PCORnet privacy policy Funder Information Declared Centers for Disease Control and Prevention , 6-NU38OT000316 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Back to top Previous Next Posted September 21, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following How age and underlying conditions affect incidence of hospitalization and death after documented COVID-19 diagnosis among individuals aged ≥20 years, a retrospective cohort study using PCORnet, April 2022 to March 2025 Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share How age and underlying conditions affect incidence of hospitalization and death after documented COVID-19 diagnosis among individuals aged ≥20 years, a retrospective cohort study using PCORnet, April 2022 to March 2025 Emilia H Koumans , Gordana Derado , Melisa M Shah , Nathan Graff , Christine Draper , Sharon Saydah , Melissa Briggs-Hagen , Joshua Denson , Michael David Kappelman , Deepika Thacker , Edward J Schenck , Kshema Nagavedu , Tegan K Boehmer , Diane Emerton , Thomas Carton , Pragna Patel , Jason P Block , PCORnet Network Partners medRxiv 2026.09.18.26363440; doi: https://doi.org/10.64898/2026.09.18.26363440 Share This Article: Copy Citation Tools How age and underlying conditions affect incidence of hospitalization and death after documented COVID-19 diagnosis among individuals aged ≥20 years, a retrospective cohort study using PCORnet, April 2022 to March 2025 Emilia H Koumans , Gordana Derado , Melisa M Shah , Nathan Graff , Christine Draper , Sharon Saydah , Melissa Briggs-Hagen , Joshua Denson , Michael David Kappelman , Deepika Thacker , Edward J Schenck , Kshema Nagavedu , Tegan K Boehmer , Diane Emerton , Thomas Carton , Pragna Patel , Jason P Block , PCORnet Network Partners medRxiv 2026.09.18.26363440; doi: https://doi.org/10.64898/2026.09.18.26363440 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (335) Cardiovascular Medicine (4834) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15980) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7067) Geriatric Medicine (734) Health Economics (1067) Health Informatics (5062) Health Policy (1438) Health Systems and Quality Improvement (1776) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16310) Intensive Care and Critical Care Medicine (1176) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7297) Nursing (369) Nutrition (1084) Obstetrics and Gynecology (1244) Occupational and Environmental Health (1006) Oncology (3618) Ophthalmology (1057) Orthopedics (398) Otolaryngology (458) Pain Medicine (474) Palliative Medicine (140) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (769) Psychiatry and Clinical Psychology (5922) Public and Global Health (9772) Radiology and Imaging (2434) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (643) Sexual and Reproductive Health (773) Sports Medicine (581) Surgery (783) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://medichelpline.com/clinical-feed/stat-news-1-kennedy-renews-attacks-on-vaccines-at-children-s-health-defense-conference.md)
- [Study says purer fentanyl won’t by itself explain U.S. overdose death decline](https://medichelpline.com/clinical-feed/stat-news-2-purer-fentanyl-won-t-solve-the-u-s-overdose-death-crisis-study-says.md)
- [Cost-Effectiveness of Ensitrelvir Post-Exposure Prophylaxis for High-Risk Household Contacts in Ja](https://medichelpline.com/clinical-feed/medrxiv-0-cost-effectiveness-of-ensitrelvir-for-covid-19-post-exposure-prophylaxis-among.md)
- [Projected preventable pneumococcal disease in Japanese adults ≥65: PCV21 versus PCV20](https://medichelpline.com/clinical-feed/medrxiv-15-estimation-of-preventable-pneumococcal-disease-burden-by-pcv20-or-pcv21-under.md)
- [Structured aerobic exercise linked to lower cancer recurrence and improved survival](https://medichelpline.com/clinical-feed/medical-news-today-0-aerobic-exercise-could-help-improve-outlook-after-cancer-treatment.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.